Advertisement

Scintigraphic Detection of Bone Metastases

  • E. K. J. Pauwels
  • H. E. Schütte
  • J. W. Arndt
  • A. van Langevelde

Abstract

Following the introduction of suitable radiotracers for skeletal imaging, the detection of malignant bone disease became one of the important fields of interest in nuclear medicine. In many nuclear medicine departments bone scans may account for more than half of all imaging procedures. In oncology many applications of bone scintigraphy have been mentioned, and it is recognized that the bone scan is no longer solely used for the mapping of bone metastases, but among other applications also for therapy monitoring and the localization of sites for biopsy or further diagnostic imaging. It should be emphasized that in an era of limited funds for health care it is important to understand how useful bone scanning is. It is the purpose of this chapter to explore the indications for bone scintigraphy in the evaluation of patients with osseous metastases. In addition to this survey the cost-effectiveness of bone scanning in relation to its diagnostic yield and the proper choice of bone seeking radiopharmaceuticals for the detection of skeletal metastases will be discussed.

Keywords

Bone Metastasis Bone Scintigraphy Bone Scanning Osseous Metastasis Skeletal Scintigraphy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Subramanian G, McAfee JG, Blair RJ et al. (1972) A potential radiopharmaceutical for skeletal imaging. J Nucl Med 13:947–950PubMedGoogle Scholar
  2. 2.
    Fogelman I, Citrin DL, McKillop JH et al. (1979) A clinical comparison of Tc-99m HEDP and Tc-99m MDP in the detection of bone metastases: concise communication. J Nucl Med 20:98–101PubMedGoogle Scholar
  3. 3.
    Wang TST, Fawwaz RA, Johnson LJ et al. (1980) Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphonic acid: concise communication. J Nucl Med 21:767–770PubMedGoogle Scholar
  4. 4.
    Unterspann S (1976) Experimental examinations on the suitability of organoaminomethane-bisphosphonic acid for bone scintigraphy by means of Tc-99m in animals. Eur J Nucl Med 1:151–154PubMedCrossRefGoogle Scholar
  5. 5.
    Pauwels EKJ, Blom J, Camps JAJ et al. (1983) A comparison between the diagnostic efficacy of Tc-99m MDP, Tc-99m DPD and Tc-99m HDP for the detection of bone metastases. Eur J Nucl Med 8:118–122PubMedCrossRefGoogle Scholar
  6. 6.
    Vorne M, Vähätalo S, Lantto T (1983) A clinical comparison of Tc-99m-DPD and two Tc- 99m MDP agents. Eur J Nucl Med 8:395–397PubMedCrossRefGoogle Scholar
  7. 7.
    Schroth HJ, Hausinger F, Garth H et al. (1984) Comparison of the kinetics of methylene- diphosphonate (MDP) and dicarboxypropan-diphosphonic acid (DPD), two radio-di- agnostics for bone scintigraphy. Eur J Nucl Med 9:529–532PubMedCrossRefGoogle Scholar
  8. 8.
    Van Duzee BF, Schaefer JA, Ball JD et al. (1984) Relative lesion detection ability of Tc- 99m HMDP and Tc-99m MDP: concise communication. J Nucl Med 25:166–169PubMedGoogle Scholar
  9. 9.
    Pauwels EKJ, Blom J, Aarts JCNM (1984) A comparison between whole body scans made at two hours and three hours after intravenous injection of Tc-99m HDP as to image quality and lesion detectability. Clin Nucl Med 9:75–78PubMedCrossRefGoogle Scholar
  10. 10.
    Rosenthall L, Stem J, Arzoumanian A (1982) A clinical comparison of MDP and DMAD. Clin Nucl Med 7:403–406PubMedCrossRefGoogle Scholar
  11. 11.
    Smith ML, Martin W, McKillop JH et al. (1984) Improved lesion detection with dimethyl- amino-diphosphonate: a report of two cases. Eur J Nucl Med 9:519–520PubMedCrossRefGoogle Scholar
  12. 12.
    Schutte HE, Park WM (1983) The diagnostic value of bone scintigraphy in patients with low back pain. Skeletal Radiol 10:1–4PubMedCrossRefGoogle Scholar
  13. 13.
    Vellenga CJLR, Pauwels EKJ, Bijvoet OLM et al. (1984) Untreated Paget disease of bone studied by scintigraphy. Radiology 153:799–805PubMedGoogle Scholar
  14. 14.
    Front D, Schneck SD, Frankel A et al. (1979) Bone metastases and bone pain in breast cancer. JAMA 242:1747–1748PubMedCrossRefGoogle Scholar
  15. 15.
    Schutte HE (1979) The influence of bone pain on the results of bone scans. Cancer 44:2039–2041PubMedCrossRefGoogle Scholar
  16. 16.
    Finn SD, Larson EB, Rudd TR et al. (1982) Clinical use of radionuclide bone imaging in a university medical center. JAMA 248:439–442CrossRefGoogle Scholar
  17. 17.
    Roberts JG, Gravelle IH, Baum M et al. (1976) Evaluation of radiography and isotopic scintigraphy for detecting skeletal metastases in breast cancer. Lancet 1:237–239PubMedCrossRefGoogle Scholar
  18. 18.
    Pauwels EKJ, Heslinga JM, Zwaveling A (1982) Value of pre-treatment and follow-up skeletal scintigraphy in operable breast cancer. Clin Oncol 8:25–32PubMedGoogle Scholar
  19. 19.
    Biersack HJ, Wegner G, Distelmaier W et al. (1980) Ossäre Metastasierung des Pro- statakarzinoms in Abhängigkeit von Tumorgröβe und Geschwulstdifferenzierung. Nuklearmedizin 19:29–32PubMedGoogle Scholar
  20. 20.
    Hooper RG, Beechler CR, Johnson MC (1978) Radioisotope scanning in initial staging of bronchogenic carcinoma. Am Rev Respir-Dis 118:279–286PubMedGoogle Scholar
  21. 21.
    Harbert JC, Rocha L, Smith FP et al. (1982) The efficacy of radionuclide bone scans in the evaluation of gynecologic cancers. Cancer 49:1040–1042PubMedCrossRefGoogle Scholar
  22. 22.
    Woolfenden JM, Pitt MJ, Durie BGM et al. (1980) Comparison of bone scintigraphy and radiography in multiple myeloma. Radiology 134:723–728PubMedGoogle Scholar
  23. 23.
    Frank JW, LeBesque S, Buchanan RB (1982) The value of bone imaging in multiple myeloma. Eur J Nucl Med 7:502–505PubMedCrossRefGoogle Scholar
  24. 24.
    Clyne CAC, Frank JW, Jenkins JD et al. (1983) The place of the Tc-99m-polyphosphonate bone scan in renal carcinoma. Br J Urol 55:174–175PubMedCrossRefGoogle Scholar
  25. 25.
    Rosen PR, Murphy KG (1984) Bone scintigraphy in the initial staging of patients with renal cell carcinoma. J Nucl Med 25:289–291PubMedGoogle Scholar
  26. 26.
    McNeil BJ, Pace PD, Gray EB et al. (1978) Pre-operative and follow-up bone scans in patients with primary carcinoma of the breast. Surg Gynecol Obstet 147:745–748PubMedGoogle Scholar
  27. 27.
    McNeil BJ (1984) Value of bone scanning in neoplastic disease. Semin Nucl Med 14:277–286PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • E. K. J. Pauwels
    • 1
  • H. E. Schütte
  • J. W. Arndt
  • A. van Langevelde
  1. 1.Department of Diagnostic Radiology, Division of Nuclear MedicineUniversity HospitalAA LeidenThe Netherlands

Personalised recommendations